Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Restless Legs Syndrome
NCT06863740Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cannabis oil in restless legs syndrome (RLS) (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoints: Incidence of Adverse Events and Serious Adverse Events at 8 weeks and Rate of Study Completion at 8 weeks. Started Jul 2025; status: recruiting.
02
Drugs
cannabis oil
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT06863740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06863740.